{
    "2020-09-30": [
        [
            {
                "time": "",
                "original_text": "【权益变动】药明康德(02359-HK)获美国资本集团增持70.52万股",
                "features": {
                    "keywords": [
                        "药明康德",
                        "美国资本集团",
                        "增持"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医疗健康行业周报 | 太美医疗获超12亿元F轮融资；海创药业获近10亿元C轮融资；基石药业与辉瑞达成战略合作",
                "features": {
                    "keywords": [
                        "太美医疗",
                        "海创药业",
                        "基石药业",
                        "辉瑞",
                        "融资",
                        "战略合作"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医疗健康"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": ""
                }
            },
            {
                "time": "",
                "original_text": "医药生物行业周报：业绩投资主线将更为明确",
                "features": {
                    "keywords": [
                        "医药生物",
                        "业绩",
                        "投资主线"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药",
                        "生物科技"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "",
                "original_text": "医疗物资出口板块拉升，迈瑞医疗、药明康德涨超2%",
                "features": {
                    "keywords": [
                        "医疗物资",
                        "出口",
                        "迈瑞医疗",
                        "药明康德"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医疗设备",
                        "医药"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}